Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults between 18 and 75 years old.
- People who have been newly diagnosed with a type of lung cancer called non-small cell lung cancer (stages IIA to IIIB), confirmed by a tissue sample, and whose cancer does not have certain specific genetic changes known as "driver gene" mutations.
- People whose scans show at least one tumour that can be measured in a specific way used in cancer research (called RECIST 1.1).
- People with a general health and activity level rated as 0 or 1 on a standard medical scale, meaning they are either fully active or have only minor limitations in physical activity.
- People who have not previously had any systemic cancer treatment or radiotherapy.
- People whose medical team, after a team-based review, has assessed them as suitable for surgery to remove the tumour, as well as for pre-surgery immune or chemotherapy treatment.
- People who are willing and able to sign a written consent form before joining the study.
- People whose lung function tests before joining confirm their lungs are working well enough to safely undergo surgery.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who decline to take part or are unable to give clear informed consent.
- People who need ongoing treatment with steroid medications (such as cortisone or prednisone) or other medicines that suppress the immune system.
- People who have used antibiotics in the three months before joining, or who currently have an infection that requires antibiotic treatment.
- People who have taken probiotic supplements or products in the three months before joining.
- People who have a blocked airway caused by the cancer, a cavity within the tumour, or active tuberculosis.
- People who have bronchiectasis (a chronic lung condition), an active lung infection, scarring of the lung tissue (pulmonary fibrosis), or diabetes that is not well controlled.
- People who have another cancer originating in a different part of the body.
- People who have already received chemotherapy or any other cancer treatment before joining the trial.
- People whose brain scans (MRI with contrast dye) confirm cancer has spread to the brain before joining.
- People who have an active or pre-existing condition where the immune system attacks the body (autoimmune disease).
- People who have serious uncontrolled health conditions, including heart failure, high blood pressure that is not well controlled, unstable chest pain (unstable angina), or a lung condition called interstitial lung disease.
- People who test positive for hepatitis B or hepatitis C and require treatment for it.
- People who have a known history of, or test positive for, HIV or AIDS.
- People who have a known allergy to any of the components of the study medications.
- People who are pregnant or breastfeeding.
- People who have previously been treated with certain types of immunotherapy drugs that target specific immune checkpoint proteins (anti-PD-1, anti-PD-L1, anti-PD-L2, or anti-CTLA-4 antibodies).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: science and technology center, China-Japan Friendship Hospital
Phone: +86 84206264
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Major pathological response (mPR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 10 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.